US OptionsDetailed Quotes
ARVN250516P7500
- 0.85
- 0.000.00%
15min DelayClose May 14 16:00 ET
0.00High0.00Low
0.85Open0.85Pre Close0 Volume1.47K Open Interest7.50Strike Price0.00Turnover380.05%IV-9.56%PremiumMay 16, 2025Expiry Date1.43Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.7432Delta0.1979Gamma3.68Leverage Ratio-0.1487Theta-0.0003Rho-2.73Eff Leverage0.0014Vega
Arvinas Stock Discussion
Sign in to post a comment
$Arvinas (ARVN.US)$ What happen bruh
2
2
Arvinas' high P/S ratio could be worrisome as revenue forecasts are not promising. The anticipated future revenues may not sustain the current positive sentiment. Without significant improvements, these prices may not be deemed reasonable.
1
Sean Cassidy expressed confidence in the company's future and the promising clinical development and commercial opportunity for the PROTAC(R) protein degrader pipeline. The company's leadership acknowledged Cassidy's pivotal role in creating Arvinas' strong financial profile.
2
$Arvinas (ARVN.US)$ I hope everyone bought that sub 14 dip! This thing has been a beast.
1
No comment yet
FMattDamon : 2027 When new FDA starts some bio will
T+32 watch list now